InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit

2026-03-25 - 13:20

BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025. Read More